Authors and Disclosures
Address correspondence to
The North American Menopause Society, 30100 Chagrin Blvd, Suite 201, Pepper Pike, OH 44124. E-mail: info@menopause.org. Website: www.menopause.org.
This position statement was developed by The North American Menopause Society (NAMS) consisting of representatives of the NAMS Board of Trustees and other experts in women's health: Stephanie S. Faubion, MD, MBA, FACP, NCMP, IF; Sheryl A. Kingsberg, PhD; Jan L. Shifren, MD, NCMP, FACOG; Caroline Mitchell, MD, MPH; Andrew M. Kaunitz, MD, FACOG, NCMP; Lisa Larkin, MD, FACP, NCMP, IF; Susan Kellogg Spadt, PhD, CRNP, IF, FCST, CSC; Amanda Clark, MD, MCR, NCMP, FACOG; James A. Simon, MD, CCD, NCMP, IF, FACOG. The Board of Trustees conducted independent review and revision and approved the position statement on May 5, 2020.
Financial disclosures/conflicts of interest
For the GSM Position Statement Editorial Panel: Dr. Faubion and Dr. Shifren report no relevant financial relationships. Dr. Kingsberg reports Consultant/Advisory Board for Amag, Astellas, Dare, Duchesney, Endoceutics, Lupin, Materna, Mitsubishi Tanaba, Ovaco, Palatin Technologies, Pfizer, Sprout, Strategic Science Technologies, TherapeuticsMD, and Viveve; Speaker for Amag and Therapeutics MD. Dr. Clark reports Consulting Fees for Butler Snow LLC; Grant Funding (paid to institution) from Pfizer. Dr. Kaunitz reports Consultant for Amag, Mithra, Pfizer; Clinical Trial Support (paid to institution) from Endoceutics, Mithra. Dr. Kellogg Spadt reports Speaker for Amag, Bonafide, TherapeuticsMD. Dr. Larkin reports Consultant/Advisory Board for Amag, Lupin, Procter & Gamble, TherapeuticsMD; Speakers' Bureau for Amag, Amgen, TherapeuticsMD. Dr. Mitchell reports Spouse Employee at Sanofi Genzyme; Consulting for Scynexis. Research Funding from Merck. Dr. Simon reports Research/Grant Support from AbbVie, Bayer Healthcare, Endoceutics, GTx, Inc, Ipsen, Myovant Sciences; Consultant for AbbVie, Amag, Bayer HealthCare, CEEK Enterprises, Covance, Dare Bioscience, Duchesnay, Hologic, KaNDy/NeRRe Therapeutics, Mitsubishi Tanabe Pharma Development America, Shionogi, Sprout2, TherapeuticsMD; Speaker for AbbVie, Amag, Duchesnay, TherapeuticsMD. For additional contributors, Ms. Develen and Ms. Method report no relevant financial relationships.
For the NAMS Board of Trustees members who were not members of the Editorial Panel: Dr. Crandall, Dr. El Khoudary, Dr. Shufelt, and Dr. Schiff report no relevant financial relationships. Dr. Thurston reports Consultant/Advisory Board for Astellas, Pfizer, Procter & Gamble, Virtue Health. Dr. Joffe reports Consultant/Advisory Board for Esai, Jazz, Merck, NeRRe/KaNDy, Sojournix; Grant/Research Support from Brigham and Women's Hospital Funds, Merck, NIH, NIA, NIMH, NCI, NeRRe/KaNDy, Pfizer, QUE Oncology, V Foundation; spouse employee for Merck, Arsenal Biosciences and Tango, consulting and equity. Dr. Liu reports Consultant/Advisory Board for Allergan, Amag, Astellas, Bayer, Daré, Ferring, Lupin, Mitsubishi, TherapeuticsMD; Research Grants from AbbVie, Allergan, Amag, Astellas, Femasys. All funds paid to the institution. Dr. Chism reports Consultant/Advisory Board for Hologic; Speakers' Bureau for Amag, Astellas, JDS Therapeutics; Royalties/Patents for Jones and Bartlett Publishing. Dr. McClung reports Consultant/Advisory Board for Amgen, Myovant; Speakers' Bureau for Amgen, Radius. Dr. Reed reports Grant/Research Support from Bayer, NIH; Royalties/Patents from UpToDate. Dr. Santoro reports Consultant/Advisory Board for Ansh Labs, Menogenix, Ogeda/Astellas; Stock/Ownership for Menogenix. Dr. Soares reports Consultant/Advisory Board for Lundbeck, Otsuka; Grant/Research Support from Ontario Research Fund, Ontario Brain Institute, AHSC AFP Innovation Fund.